However, although our study confirms this finding in the leptin receptor-deficient mice, it also further augments our knowledge about the effects of such therapy on bone quality that is compromised in animal models of T2DM but also in human diabetic individuals. Here, LEPR is linked to type 2 diabetes mellitus.